Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro

Climacteric

Volumn 17, Issue 6, 2014, Pages 682-691

  Chen, F P ^a   Chien, M H ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

GENISTEIN; MCF 10A NORMAL BREAST CELLS; MCF 7 BREAST CANCER CELLS; PHYTOESTROGENS; QUERCETIN; RESVERATROL

Indexed keywords

CASPASE 3; CASPASE 9; CYTOCHROME C; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FAS ASSOCIATED PROTEIN WITH DEATH DOMAIN; FAS LIGAND; GENISTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHYTOESTROGEN; PROTEIN BID; PROTEIN KINASE B; QUERCETIN; RESVERATROL; UNCLASSIFIED DRUG; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; BREAST CELL; CELL GROWTH; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; MTT ASSAY; NICK END LABELING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BREAST; BREAST TUMOR; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; TUNEL ASSAY;

APOPTOSIS; BREAST; BREAST NEOPLASMS; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENISTEIN; HUMANS; IN SITU NICK-END LABELING; MCF-7 CELLS; PHYTOESTROGENS; QUERCETIN; SIGNAL TRANSDUCTION; STILBENES;

EID: 84911449691     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2014.937688     Document Type: Article

References (37)

1. Adlercreutz H. Phyto-oestrogens and cancer. L ancet Oncol 2002; 3: 364-73
2. Ingram D., Sanders K., Kolybaba M., Lopez D. Case-control study of phyto-estrogens and breast cancer. Lancet 1997; 350: 990-4
3. Shu X-O., Jin F, Dai Q., et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev 2001; 10: 483-8
4. Murkies A., Dalais F S, B riganti E., et al. Phytoestrogens and breast cancer in postmenopausal women: a case control study. Menopause 2000; 7: 289-96
5. Key T, Sharp G., Appleby P, et al. Soya foods and breast cancer risk: a prospective study in Hiroshima and Nagasaki, Japan. Br J Cancer 1999; 81: 1248-56
6. den Tonkelaar I, Keinan-Boker L., Van't Veer P, et al. Urinary phytoestrogens and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 2001; 10: 223-8
7. Horn-Ross P, Hoggatt KJ, West DW., et al. Recent diet and breast cancer risk: the California Teachers Study (USA). Cancer Causes Control 2002; 13: 407-15
8. Grace PB., Taylor JI, Low YL., et al. Phytoestrogen concentrations in serum and spot urine as biomarkers for dietary phytoestrogen intake and their relation to breast cancer risk in European prospective investigation of cancer and nutrition-norfolk. Cancer Epidemiol Biomarkers Prev 2004; 13: 698-708
9. McCarty M F. Isofl avones made simple-genistein's agonist activity for the beta-Type estrogen receptor mediates their health benefi ts. Med Hypotheses 2006; 66: 1093-114
10. Seo H S., Denardo D G., Jacquot Y., et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006; 99: 121-34
11. Schmitt E., Lehmann L., Metzler M., Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol Lett 2002; 136: 133-42
12. van Der Woude H., Ter Veld MG., Jacobs N., van Der Saag PT., Murk AJ., Rietjens IM. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res 2005; 49: 763-71
13. Setchell KD., Brown NM., Lydeking-Olsen E. The clinical importance of the metabolite equol-A clue to the effectiveness of soy and its isofl avones. J Nutr 2002; 132: 3577-84
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63
15. Negoescu A., Guillermet C., Lorimier P, Brambilla E., Labat-Moleur F. Importance of DNA fragmentation in apoptosis with regard to TUNEL specifi city. Biomed Pharmacother 1998; 52: 252-8
16. Harris DM., Besselink E., Henning SM., Go VLW., Heber D. Phytoestrogens induce differential estrogen receptor alpha- or betamediated responses in transfected breast cancer cells. Exp Biol Med 2005; 230: 558-68
17. Soule H D., Maloney T M., Wolman S R., et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990; 50: 6075-86
18. Pratt SE., Pollak MN. Estrogen and antiestrogen modulation of MCF-7 human breast cancer cell proliferation is associated with specifi c alterations in accumulation of insulin-like growth factorbinding proteins in conditioned media. Cancer Res 1993; 53: 5193-8
19. Maggiolini M., Bonofi glio D., Marsico S., et al. Estrogen receptor alpha mediates the proliferative but not the cytotoxic dose-dependent effects of two major phytoestrogens on human breast cancer cells. Mol Pharmacol 2001; 60: 595-602
20. Paunesku T., Mittal S., Protic M., et al. Proliferating cell nuclear antigen (PCNA): ringmaster of the genome. Int J Radiat Biol 2001; 77: 1007-21
21. Devarajan E., Sahin AA., Chen JS, et al. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 2002; 21: 8843-51
22. Seo H S., Denardo D G., Jacquot Y., et al. Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha. Breast Cancer Res Treat 2006; 99: 121-34
23. Schmitt E., Lehmann L., Metzler M., Stopper H. Hormonal and genotoxic activity of resveratrol. Toxicol Lett 2002; 136: 133-42
24. van Der Woude H., Ter Veld MG., Jacobs N., van Der Saag PT., Murk AJ., Rietjens IM. The stimulation of cell proliferation by quercetin is mediated by the estrogen receptor. Mol Nutr Food Res 2005; 49: 763-71
25. Upadhyay S., Neburi M., Chinni SR., Alhasan S., Miller F, Sarkar FH. Differential sensitivity of normal and malignant breast epithelial cells to genistein is partly mediated by p21(WAF1). Clin Cancer Res 2001; 7: 1782-9
26. Hill MM., Hemmings BA. Inhibition of protein kinase B/Akt. Implications for cancer therapy. Pharmacol Ther 2002; 93: 243-51
27. Pozo-Guisado E., Merino JM, Mulero-Navarro S., et al. Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with downregulation of Bcl-2 and NF-kappaB. Int J Cancer 2005; 115: 74-84
28. Lee Y K., Park O J. Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells. Oncol Rep 2010; 24: 1493-7
29. Gong L., Li Y., Nedeljkovic-Kurepa A., Sarkar F H. Inactivation of NF-kappaB by genistein is mediated via Akt signaling pathway in breast cancer cells. Oncogene 2003; 22: 4702-9
30. Schmitz I., Kirchhoff S., Krammer P H. Regulation of death receptor-mediated apoptosis pathways. Int J Biochem Cell Biol 2000; 32: 1123-36
31. Dejean L M., Martinez-Caballero S., Manon S., Kinnally KW. Regulation of the mitochondrial apoptosis-induced channel, MAC, by BCL-2 family proteins. Biochim Biophys Acta 2006; 1762: 191-201
32. Lehmann L., Esch H L., Wagner J, Rohnstock L., Metzler M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of daidzein in cultured human Ishikawa cells. Toxicol Lett 2005; 158: 72-86
33. Bowers J L., Tyulmenkov V V, J ernigan S C., Klinge C M. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta. Endocrinology 2000; 141: 3657-67
34. McDonnell DP. The molecular determinants of estrogen receptor pharmacology. Maturitas 2004; 48(Suppl 1): S7-12
35. Omoto Y, Eguchi H., Yamamoto-Yamaguchi Y, Hayashi S. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function Differently in breast cancer cell line MCF7. Oncogene 2003; 22: 5011-20
36. Strom A., Hartman J, Foster JS, Kietz S., Wimalasena J, Gustafsson JA. Estrogen receptor beta inhibits 17beta-estradiolstimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA 2004; 101: 1566-71
37. Koehler K F, H elguero L A., Haldosen L A., Warner M., Gustafsson JA. Refl ections on the discovery and signifi cance of estrogen receptor beta. Endocr Rev 2005; 26: 465-78